Results 211 to 220 of about 9,194 (267)

Radium-223 in treatment of castration-resistant prostate cancer with skeletal metastases

, 2017
В. Б. Матвеев, А. С. Маркова   +1 more
openalex   +2 more sources

Evaluation of confirmatory data following the Article 12 MRL review for ametoctradin

EFSA Journal, Volume 24, Issue 1, January 2026.
Abstract The applicant BASF SE submitted a request to the competent national authority in Germany to evaluate the confirmatory data for ametoctradin, which had been identified as unavailable in the framework of the MRL review under Article 12 of Regulation (EC) No 396/2005.
European Food Safety Authority (EFSA), Giulia Bellisai, Giovanni Bernasconi, Luis Carrasco Cabrera, Irene Castellan, Monica del Aguila, Lucien Ferreira, Luna Greco, Renata Leuschner, Andrea Mioč, Stefanie Nave, Hermine Reich, Silvia Ruocco, Alessia Pia Scarlato, Marta Szot, Anne Theobald, Manuela Tiramani, Alessia Verani, Elena Zioga   +18 more
wiley   +1 more source

Investigation of the safety of Radium-223 chloride in combination with external beam radiotherapy for bone metastases of prostate cancer. [PDF]

J Radiat Res
Makino S, Miyazawa K, Katsuoka Y, Ooe T, Aikawa K, Segawa A, Kobayashi H.   +6 more
europepmc   +1 more source

Enzalutamide Prior to Radium-223 Is Associated with Better Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Compared to Abiraterone-A Retrospective Study. [PDF]

Cancers (Basel), 2023
Chen HX, Tsai LH, Chang CH, Wu HC, Lin CC, Lin CH, Yeh CC, Yang CR, Lien CS, Chang YH, Liang JA, Chen GH, Hsiao PJ, Hsieh PF, Huang CP.   +14 more
europepmc   +1 more source

Asthma Remission in Adults: Role of Age at Asthma Onset, Smoking, Obesity, and Allergic Rhinitis

Allergy, Volume 81, Issue 1, Page 288-291, January 2026.
Reshed Abohalaka, Selin Ercan, Lauri Lehtimäki, Daniil Lisik, Saliha Selin Ozuygur Ermis, Linda Ekerljung, Helena Backman, Madeleine Rådinger, Bright I. Nwaru, Hannu Kankaanranta   +9 more
wiley   +1 more source

Real-world utilization patterns and survival in men with metastatic prostate cancer treated with Radium-223 in the United States. [PDF]

Prostate Cancer Prostatic Dis
Raval AD, Zhang Y, Korn M, Constantinovici N, McKay RR.   +4 more
europepmc   +1 more source

The safety and efficacy of radium-223 dichloride for the treatment of advanced prostate cancer [PDF]

, 2016
James M. Wilson, Christopher Parker
openalex   +1 more source

Darolutamide in Combination with Radium-223 Exhibits Synergistic Antitumor Efficacy in LNCaP Prostate Cancer Models. [PDF]

Int J Mol Sci
Hagemann UB, Schatz CA, Suominen MI, Schlicker A, Knuuttila M, Wilson T, Alhoniemi E, Käkönen SM, Haendler B, Scholz A.   +9 more
europepmc   +1 more source

Post-marketing surveillance of radium-223 chloride in Japanese patients with castration-resistant prostate cancer with bone metastasis-final analysis of 3-year extended follow-up focusing on bone fractures. [PDF]

Int J Clin Oncol
Masumori N, Hosono M, Takahashi S, Kakehi Y, Uemura H, Sunaya T, Shimotsumagari K, Matsuba Y, Adachi M, Kakiuchi H, Kinuya S.   +10 more
europepmc   +1 more source

Additional file 3: of Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program

, 2019
Axel Heidenreich, Silke Gillessen, Daniel Heinrich, Daniel Keizman, Joe O’Sullivan, Joan Carles, Manfred Wirth, Kurt Miller, John A. Reeves, Monica Seger, Sten Nilsson, Fred Saad   +11 more
openalex   +1 more source